Insulin: The high price of not going high
In June at the request of HealthCentral, I wrote two items discussing the high price of insulin. One is an information item about four main factors which cause insulin prices to be higher than we would like. In it, I cite Manufacturers, Pharmacy Benefit Managers (PBM), Employer Health Plan Design and Users each as contributing to the increasing cost insulin.
In truth, it is all four of these factors plus more that is causing the price of insulin to escalate. I hope my article “Four Factors Are Driving Up The Price Of Insulin in the U.S.” is informative and maybe a little upsetting.
The second item is an editorial which is a call to action for the diabetes community. The title of the piece is “Second Opinion: Diabetes Patients who Use Insulin Need To Object To Rising Drug Costs” may be a bit more controversial and I also hope more thought provoking. In it, I call on people who use insulin to spend at least as much time talking about the cost of insulin as we do technology. I am not saying technology is bad by any means. But unless we focus effort on the cost of insulin we cannot expect others to pay attention.
I hope you will take a moment to read both. I am interested in your ideas on the subject and how I can better advocate in this shared interest. Those of us with type 1 diabetes have a lot riding on how this issue is resolved. I hope my thoughts contribute in a positive way to the discussion.